140
Participants
Start Date
December 31, 2006
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
QR-333
QR-333 or placebo will be applied three times a day for 12 weeks
Kaleida Health, Diabetes Center of WNY, Buffalo
ECU Diabetes Research Center, Brody School of Medicine, Greenville
Hartwell Research Group / Anderson Family Care, Anderson
Metabolic Research Institute, Inc., West Palm Beach
Stedman Clinical Trails, Tampa
Renstar Medical Research, Ocala
Baptist Clinical Research, Pensacola
Parkway Medical Center, Birmingham
Seale Harris Clinic / Alliance Clinical Research, Birmingham
A&A Pain Institute, St Louis
UT Southwestern Medical Center at Dallas, Dallas
dgd Research, San Antonio
Endeavor Clinical Trials, PA, San Antonio
Advanced Medical Research, LLC, Lakewood
Pacific Sleep Medicine Services, Inc, Fountain Valley
Diablo Clinical Research, Inc., Walnut Creek
Rainier Clinical Research Center, Inc, Renton
Rwjms/Umdnj, New Brunswick
Land Clinical Studies, West Caldwell
Quigley Pharma, Inc.
INDUSTRY